India M&A hits $100b

JPMorgan sees India outbound M&A rising as firms move to secure supply chains

JPMorgan projects rising Indian outbound M&A to secure supply chains, exemplified by Sun Pharma's $11.75 billion Organon deal. Total M&A hit $100 billion in H1 2026, driven by needs for critical miner